3,8-dibromo-7-hydroxy-4-methyl-2H-chromen-2-one

3,8-DIBROMO–7-HYDROXY–4-METHYL–2H–CHROMEN–2–ONE is a synthetic small molecule belonging to the class of hydroxycoumarins. It is structurally characterized as a dibrominated derivative of methylhydroxycoumarin. The compound has been cataloged in chemical and drug databases as an experimental agent but does not have any approved medical indications or established clinical use. Its mechanism of action and biological targets are not well defined in the literature; however, it has been referenced in some datasets for potential interaction with protein kinases such as casein kinase II subunit alpha (CSNK2A1), though this association remains speculative and unvalidated for therapeutic application[1][2][5].

Other names

3,8-dibromo-7-hydroxy-4-methylchromen-2-one3,8-dibromo-4-methyl-7-hydroxycoumarin3,8-dibromo-7-hydroxy-4-methylcoumarin3,8-dibromo-7-hydroxy-4-methylbenzopyranone90876–67–8